- Investing Ideas
- /
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
24
Companies with a Value score of at least 3, ordered by Value score
24 companies
Merck
Market Cap: AR$199.7b
Operates as a healthcare company worldwide.
MRK
AR$22,190.00
7D
-8.6%
1Y
-21.2%
Biogen
Market Cap: AR$20.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$14,640.00
7D
-12.0%
1Y
-18.2%
Johnson & Johnson
Market Cap: AR$425.3b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
AR$16,440.00
7D
-7.0%
1Y
25.0%
Bristol-Myers Squibb
Market Cap: US$91.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$15.21
7D
-1.9%
1Y
n/a
Bristol-Myers Squibb
Market Cap: AR$91.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$20,520.00
7D
-11.2%
1Y
0.2%
Johnson & Johnson
Market Cap: AR$425.5b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
DJNJ3
AR$1,300.00
7D
0%
1Y
-18.8%
Bayer
Market Cap: AR$22.5b
Operates as a life science company worldwide.
BAYN
AR$3,323.26
7D
0%
1Y
n/a
Pfizer
Market Cap: AR$137.2b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
AR$8,375.00
7D
-7.0%
1Y
-5.7%
Biogen
Market Cap: US$20.4b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$10.51
7D
-7.0%
1Y
-29.9%
Merck
Market Cap: US$199.7b
Operates as a healthcare company worldwide.
MRKD
US$16.40
7D
-1.5%
1Y
-30.8%
Johnson & Johnson
Market Cap: US$425.3b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJD
US$12.06
7D
-0.4%
1Y
8.6%
GSK
Market Cap: US$60.1b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$10.19
7D
0.8%
1Y
n/a
Novartis
Market Cap: AR$189.4b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$42,880.00
7D
-6.3%
1Y
20.1%
Pfizer
Market Cap: US$137.2b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFED
US$6.10
7D
0.8%
1Y
-17.5%
Novartis
Market Cap: US$189.4b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$31.45
7D
0.2%
1Y
10.7%
GSK
Market Cap: AR$59.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$14,010.00
7D
-7.0%
1Y
11.9%
Gilead Sciences
Market Cap: AR$141.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$39,540.00
7D
-5.9%
1Y
56.6%
Amgen
Market Cap: US$154.4b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$9.55
7D
2.6%
1Y
-14.7%
Thermo Fisher Scientific
Market Cap: US$177.4b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMOD
US$21.60
7D
-0.9%
1Y
n/a
Vertex Pharmaceuticals
Market Cap: AR$97.4b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
AR$5,205.00
7D
-8.8%
1Y
n/a
Amgen
Market Cap: AR$154.4b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$12,910.00
7D
-5.9%
1Y
0.5%
Thermo Fisher Scientific
Market Cap: AR$177.4b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
AR$29,660.00
7D
-7.5%
1Y
-11.0%
Vertex Pharmaceuticals
Market Cap: US$97.4b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTXD
US$3.90
7D
2.1%
1Y
n/a
Gilead Sciences
Market Cap: US$141.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$28.80
7D
2.9%
1Y
38.1%